We are live on ! Find out more
Tirschwell & Loewy

Tirschwell & Loewy Portfolio holdings

AUM $731M Turnover 5.8%
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+12.63%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
–
AUM
$731M
AUM Growth
+$71M
Cap. Flow
-$10.6M
Cap. Flow %
-1.45%
Top 10 Hldgs %
44.36%
Holding
69
New
1
Increased
14
Reduced
29
Closed
3
Avg Time Held
4.4 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
3.6 years

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$3.43M
2
HSIC icon
Henry Schein
HSIC
+$952K
3
INGN icon
Inogen
INGN
+$375K
4
PYPL icon
PayPal
PYPL
+$312K
5
RTN
Raytheon Company
RTN
+$270K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$10.3M
2
BIIB icon
Biogen
BIIB
+$690K
3
GTX icon
Garrett Motion
GTX
+$534K
4
ADI icon
Analog Devices
ADI
+$478K
5
BF.B icon
Brown-Forman Class B
BF.B
+$458K

Sector Composition

Rank Sector Weight
1 Healthcare 41.81%
2 Technology 12.76%
3 Consumer Discretionary 11.88%
4 Miscellaneous 9.95%
5 Industrials 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MA icon
1
Mastercard
MA
$539B
$37.6M 5.14%
159,700
-150
-0.1% -$32.3K
2016 Q1
12 quarters
CGNX icon
2
Cognex
CGNX
$9.28B
$37M 5.06%
727,350
-4,200
-0.6% -$201K
2013 Q2
23 quarters
TIF
3
DELISTED
Tiffany & Co.
TIF
$34.6M 4.73%
327,555
-3,875
-1% -$356K
2013 Q2
23 quarters
ADI icon
4
Analog Devices
ADI
$192B
$34.2M 4.68%
324,896
-4,760
-1% -$478K
2013 Q2
23 quarters
DXCM icon
5
DexCom
DXCM
$32.6B
$33.6M 4.6%
1,130,156
-3,860
-0.3% -$136K
2013 Q2
23 quarters
DHR icon
6
Danaher
DHR
$159B
$32.9M 4.5%
280,901
-925
-0.3% -$94.8K
2013 Q2
23 quarters
IDXX icon
7
Idexx Laboratories
IDXX
$44B
$31.8M 4.35%
142,280
-1,285
-0.9% -$265K
2013 Q2
23 quarters
PODD icon
8
Insulet
PODD
$9.8B
$28.2M 3.86%
296,745
-900
-0.3% -$77.1K
2014 Q2
19 quarters
JNJ icon
9
Johnson & Johnson
JNJ
$610B
$26.9M 3.67%
192,085
-1,550
-0.8% -$208K
2013 Q2
23 quarters
BF.B icon
10
Brown-Forman Class B
BF.B
$13.1B
$26.8M 3.66%
507,221
-9,442
-2% -$458K
2013 Q2
23 quarters
NEOG icon
11
Neogen
NEOG
$2.59B
$25M 3.43%
872,852
-1,912
-0.2% -$57.8K
2013 Q2
23 quarters
HON icon
12
Honeywell
HON
$67B
$24.5M 3.36%
163,854
-955
-0.6% -$133K
2013 Q2
23 quarters
RTN
13
DELISTED
Raytheon Company
RTN
$24.5M 3.35%
134,567
+1,550
+1% +$270K
2013 Q2
23 quarters
SBUX icon
14
Starbucks
SBUX
$111B
$22.7M 3.1%
305,056
-1,100
-0.4% -$75.6K
2016 Q4
9 quarters
ABMD
15
DELISTED
Abiomed Inc
ABMD
$21.1M 2.89%
73,941
+90
+0.1% +$29.9K
2015 Q4
13 quarters
ROST icon
16
Ross Stores
ROST
$76.1B
$20M 2.73%
214,511
-675
-0.3% -$61.9K
2013 Q2
23 quarters
NVO icon
17
Novo Nordisk
NVO
$170B
$19.7M 2.7%
754,900
-7,700
-1% -$189K
2013 Q2
23 quarters
MTD icon
18
Mettler-Toledo International
MTD
$32.6B
$17.1M 2.34%
23,665
-255
-1% -$166K
2016 Q2
11 quarters
INGN icon
19
Inogen
INGN
$169M
$15M 2.06%
157,640
+3,005
+2% +$375K
2015 Q4
13 quarters
BIIB icon
20
Biogen
BIIB
$34.7B
$14.9M 2.04%
63,141
-2,192
-3% -$690K
2013 Q2
23 quarters
AMGN icon
21
Amgen
AMGN
$234B
$14M 1.92%
73,850
-1,050
-1% -$201K
2013 Q2
23 quarters
HSIC icon
22
Henry Schein
HSIC
$9.6B
$13.9M 1.9%
265,730
+15,775
+6% +$952K
2013 Q2
23 quarters
PYPL icon
23
PayPal
PYPL
$48.2B
$12.8M 1.75%
123,245
+3,300
+3% +$312K
2018 Q4
1 quarter
CRM icon
24
Salesforce
CRM
$196B
$11.9M 1.63%
75,200
+110
+0.1% +$17K
2018 Q4
1 quarter
ITW icon
25
Illinois Tool Works
ITW
$77B
$11.2M 1.53%
78,001
+125
+0.2% +$17.3K
2013 Q2
23 quarters
1
2 3

Similar funds

IAS
INR Advisory Services Media, Pennsylvania $786M AUM 2.23% 1-Year Est. Return
Aviance Capital Management
Aviance Capital Management Sarasota, Florida $668M AUM 6.48% 1-Year Est. Return
MB Financial Bank - Trust Department
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return
Steinberg Global Asset Management
Steinberg Global Asset Management Boca Raton, Florida $639M AUM 11.04% 1-Year Est. Return
AT Bancorp
AT Bancorp Dubuque, Iowa $823M AUM 0.35% 1-Year Est. Return
NF Trinity Capital
NF Trinity Capital Central, Hong Kong $626M AUM 3.16% 1-Year Est. Return
Daruma Capital Management
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
DSI
Daiwa SB Investments Tokyo, Japan $506M AUM 11% 1-Year Est. Return

Tirschwell & Loewy's Q1 2019 Portfolio in Review

As of Q1 2019, Tirschwell & Loewy held 69 positions worth $731M, up 11% from $660M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tirschwell & Loewy's Q1 2019 filing shows 1 new, 14 increased, 29 reduced and 3 closed positions. Its largest new stake was AT&T: 9,097 shares worth $215K. The largest sale was AbbVie, an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Tirschwell & Loewy's largest Q1 2019 buy was AT&T: 9,097 shares worth $215K.
  • Tirschwell & Loewy added most to Illumina in Q1 2019, an estimated $3.43M increase.
  • Tirschwell & Loewy's biggest Q1 2019 reduction was Biogen, cutting an estimated $690K.
  • Tirschwell & Loewy fully exited AbbVie in Q1 2019, selling an estimated $10.3M.
  • Tirschwell & Loewy's ten largest holdings make up 44% of its $731M portfolio in Q1 2019.
  • Tirschwell & Loewy opened 1 new position and closed 3 in Q1 2019.
  • Tirschwell & Loewy's portfolio value rose 11% quarter-over-quarter to $731M.

Based on Tirschwell & Loewy's 13F filing for Q1 2019, filed 3 Apr 2019.